Identification of a novel aFGF-binding peptide with anti-tumor effect on breast cancer from phage display library

Biochemical and Biophysical Research Communications

Volumn 445, Issue 4, 2014, Pages 795-801

  Dai, Xiaoyong ^a   Cai, Cuizan ^a   Xiao, Fei ^b   Xiong, Yaoling ^a   Huang, Yadong ^a   Zhang, Qihao ^a   Xiang, Qi ^a   Lou, Guofeng ^a   Lian, Mengyang ^a   Su, Zhijian ^a   Zheng, Qing ^a  

^a JINAN UNIVERSITY   (China)

^b MEDICAL COLLEGE OF JINAN UNIVERSITY   (China)

Author keywords

Acidic fibroblast growth factor; Breast cancer; Cell cycle; Phage display; Proliferation

Indexed keywords

AMINO ACID; CELL PROTEIN; CYCLIN D1; CYCLINE; FIBROBLAST GROWTH FACTOR 1; FIBROBLAST GROWTH FACTOR RECEPTOR; FIBROBLAST GROWTH FACTOR RECEPTOR 1; HEPTAPEPTIDE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PEPTIDE AP8; PROTEIN KINASE B; PROTEIN PA2G4; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; BIOPANNING; BREAST CANCER; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CONTROLLED STUDY; HUMAN; HUMAN CELL; NONHUMAN; PHAGE DISPLAY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR AFFINITY; VASCULAR ENDOTHELIUM;

ACIDIC FIBROBLAST GROWTH FACTOR; BREAST CANCER; CELL CYCLE; PHAGE DISPLAY; PROLIFERATION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; AMINO ACID SEQUENCE; ANTINEOPLASTIC AGENTS; BREAST; BREAST NEOPLASMS; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; ENZYME ACTIVATION; FEMALE; FIBROBLAST GROWTH FACTOR 1; HUMANS; MAP KINASE SIGNALING SYSTEM; PEPTIDE LIBRARY; PEPTIDES; PROLIFERATING CELL NUCLEAR ANTIGEN; PROTO-ONCOGENE PROTEINS C-AKT; RNA-BINDING PROTEINS;

EID: 84897134859     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2014.02.022     Document Type: Article

References (29)

1. R.A. Payson, H. Canatan, M.A. Chotani, W.P. Wang, S.E. Harris, R.L. Myers, and I.M. Chiu Cloning of two novel forms of human acidic fibroblast growth factor (aFGF) mRNA Nucleic Acids Res. 21 1993 489 495
2. A. Beenken, and M. Mohammadi The FGF family: biology, pathophysiology and therapy Nat. Rev. Drug Discov. 8 2009 235 253
3. M. Mohammadi, S.K. Olsen, and O.A. Ibrahimi Structural basis for fibroblast growth factor receptor activation Cytokine Growth Factor Rev. 16 2005 107 137
4. M. Korc, and R.E. Friesel The role of fibroblast growth factors in tumor growth Curr. Cancer Drug Targets 9 2009 639 651
5. M. Rusnati, and M. Presta Fibroblast growth factors/fibroblast growth factor receptors as targets for the development of anti-angiogenesis strategies Curr. Pharm. Des. 13 2007 2025 2044
6. C. DeSantis, R. Siegel, P. Bandi, and A. Jemal Breast cancer statistics, 2011 CA-Cancer J. Clin. 61 2011 2011 409 418
7. R. Siegel, D. Naishadham, and A. Jemal Cancer statistics, 2013 CA-Cancer J. Clin. 63 2013 2013 11 30
8. U. Veronesi, P. Boyle, A. Goldhirsch, R. Orecchia, and G. Viale Breast cancer Lancet 365 2005 1727 1741
9. W.L. Donegan Tumor-related prognostic factors for breast cancer CA-Cancer J. Clin. 47 1997 28 51
10. F. Penault-Llorca, F. Bertucci, J. Adelaide, P. Parc, F. Coulier, J. Jacquemier, D. Birnbaum, and O. deLapeyriere Expression of FGF and FGF receptor genes in human breast cancer Int. J. Cancer 61 1995 170 176
11. N. Yoshimura, H. Sano, A. Hashiramoto, R. Yamada, H. Nakajima, M. Kondo, and T. Oka The expression and localization of fibroblast growth factor-1 (FGF-1) and FGF receptor-1 (FGFR-1) in human breast cancer Clin. Immunol. Immunopathol. 89 1998 28 34
12. M. Relf, S. LeJeune, P.A. Scott, S. Fox, K. Smith, R. Leek, A. Moghaddam, R. Whitehouse, R. Bicknell, and A.L. Harris Expression of the angiogenic factors vascular endothelial cell growth factor, acidic and basic fibroblast growth factor, tumor growth factor beta-1, platelet-derived endothelial cell growth factor, placenta growth factor, and pleiotrophin in human primary breast cancer and its relation to angiogenesis Cancer Res. 57 1997 963 969
13. O.A. Ibrahimi, F.M. Zhang, A.V. Eliseenkova, R.J. Linhardt, and M. Mohammadi Proline to arginine mutations in FGF receptors 1 and 3 result in Pfeiffer and Muenke craniosynostosis syndromes through enhancement of FGF binding affinity Hum. Mol. Genet. 13 2004 69 78
14. A.M. Chioni, and R. Grose FGFR1 cleavage and nuclear translocation regulates breast cancer cell behavior J. Cell Biol. 197 2012 801 817
15. Johanna K. Ruohola, Tiina P. Viitanen, Eeva M. Valve, Jani A. Seppänen, Niina T. Loponen, Jaakko J. Keskitalo, Päivi T. Lakkakorpi, and Pirkko L. Härkönen Enhanced invasion and tumor growth of fibroblast growth factor 8b-overexpressing MCF-7 human breast cancer cells Cancer Res. 61 2001 4229 4237
16. M. Antoine, W. Wirz, C.G. Tag, M. Mavituna, N. Emans, T. Korff, V. Stoldt, A.M. Gressner, and P. Kiefer Expression pattern of fibroblast growth factors (FGFs), their receptors and antagonists in primary endothelial cells and vascular smooth muscle cells Growth Factors 23 2005 87 95
17. H.H. Xiaoping Wu, Cong Wang, Shaoqiang Lin, Yadong Huang, Yi Wang, Guang Liang, Qiuxia Yan, Jian Xiao, Jianzhang Wu, Yongguang Yang, and Xiaokun Li Identification of a novel peptide that blocks basic fibroblast growth factor-mediated cell proliferation Oncotarget 4 2013 1819 1828
18. M. Fu, C. Wang, Z. Li, T. Sakamaki, and R.G. Pestell Minireview: Cyclin D1: normal and abnormal functions Endocrinology 145 2004 5439 5447
19. J.T. Zhang, and Y. Liu Use of comparative proteomics to identify potential resistance mechanisms in cancer treatment Cancer Treat. Rev. 33 2007 741 756
20. J. Kang, G. Zhao, T. Lin, S. Tang, G. Xu, S. Hu, Q. Bi, C. Guo, L. Sun, S. Han, Q. Xu, Y. Nie, B. Wang, S. Liang, J. Ding, and K. Wu A peptide derived from phage display library exhibits anti-tumor activity by targeting GRP78 in gastric cancer multidrug resistance cells Cancer Lett. 339 2013 247 259
21. D.G. Bae, T.D. Kim, G. Li, W.H. Yoon, and C.B. Chae Anti-Flt1 peptide, a vascular endothelial growth factor receptor 1-specific hexapeptide, inhibits tumor growth and metastasis Clin. Cancer Res. 11 2005 2651 2661
22. D.A. Yardley, L. Hart, L. Bosserman, M.N. Salleh, D.M. Waterhouse, M.K. Hagan, P. Richards, M.L. DeSilvio, J.M. Mahoney, and Y. Nagarwala Phase II study evaluating lapatinib in combination with nab-paclitaxel in HER2-overexpressing metastatic breast cancer patients who have received no more than one prior chemotherapeutic regimen Breast Cancer Res. Treat. 137 2013 457 464
23. V. Knights, and S.J. Cook De-regulated FGF receptors as therapeutic targets in cancer Pharmacol. Ther. 125 2010 105 117
24. W. Wang, X. Chen, T. Li, Y. Li, R. Wang, D. He, W. Luo, X. Li, and X. Wu Screening a phage display library for a novel FGF8b-binding peptide with anti-tumor effect on prostate cancer Exp. Cell Res. 319 2013 1156 1164
25. X.M. Xia, A.W. Cheng, T. Lessor, Y.X. Zhang, and A.W. Hamburger Ebp1, an ErbB-3 binding protein, interacts with Rb and affects Rb transcriptional regulation J. Cell. Physiol. 187 2001 209 217
26. C.J. Sherr G1 phase progression: cycling on cue Cell 79 1994 551 555
27. J.B.J. Lukas, and J. Bartek Convergence of mitogenic signalling cascades from diverse classes of receptors at the cyclin D-cyclin-dependent kinase-pRb-controlled G1 checkpoint Mol. Cell. Biol. 16 1996 6917 6925
28. S. Koundrioukoff, Z.O. Jonsson, S. Hasan, R.N. de Jong, P.C. van der Vliet, M.O. Hottiger, and U. Hubscher A direct interaction between proliferating cell nuclear antigen (PCNA) and Cdk2 targets PCNA-interacting proteins for phosphorylation J. Biol. Chem. 275 2000 22882 22887
29. C.F. Welsh, K. Roovers, J. Villanueva, Y.Q. Liu, M.A. Schwartz, and R.K. Assoian Timing of cyclin D1 expression within G1 phase is controlled by Rho Nat. Cell Biol. 3 2001 950 957